References
- Khandaker GM, Dantzer R, Jones PB. Immunopsychiatry: important facts. Psychol Med [Internet]. 2017;47(13):2229–2237. Available from: https://www.cambridge.org/core/product/identifier/S0033291717000745/type/journal_article
- Teixeira AL, Bauer ME. Immunopsychiatry: a clinician’s introduction to the immune basis of Mental disorders. 1st. Teixeira AL, Bauer ME, editors. New York: Oxford University Press; 2019.
- Granerod J, Ambrose HE, Davies NWS, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis. 2010;10(12):835–844. Internet.
- Dubey D, SJ P, CR K, et al. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol. [Internet]. 2018;83:166–177. Available from. https://onlinelibrary.wiley.com/doi/10.1002/ana.25131
- Dalmau J, Graus F. Antibody-Mediated Encephalitis. In: AH R, editor. N Engl J Med. [Internet]. 2018;378:840–851. Available from. http://link.springer.com/10.1007/978-88-470-5755-5_15.
- Kayser MS, Titulaer MJ, Gresa-Arribas N, et al. Frequency and characteristics of isolated psychiatric episodes in anti– n -methyl- d -aspartate receptor encephalitis. JAMA Neurol. [Internet]. 2013;70(9):1133. Available from. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71278520
- Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. [Internet]. 2013;12(2):157–165. Available from. https://linkinghub.elsevier.com/retrieve/pii/S1474442212703101
- Thompson J, Bi M, Murchison AG, et al. The importance of early immunotherapy in patients with faciobrachial dystonic seizures. Brain. [Internet]. 2018;141(2):348–356. Available from. https://academic.oup.com/brain/article/141/2/348/4759474
- Cui J, Bu H, He J, et al. The gamma-aminobutyric acid-B receptor (GABAB) encephalitis: clinical manifestations and response to immunotherapy. Int J Neurosci. 2017;128(7):627–633. Internet
- Graus F, Vogrig A, Muñiz-Castrillo S, et al. Updated diagnostic criteria for paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflammation. [Internet]. 2021;8(4):e1014. Available from. http://nn.neurology.org/lookup/doi/10.1212/NXI.0000000000001014. .
- Wandinger K-P, Leypoldt F, Junker R. Autoantibody-Mediated Encephalitis. Dtsch Aerzteblatt Online [Internet]. 2018;115:666–673. Available from. https://www.aerzteblatt.de/10.3238/arztebl.2018.0666
- Gable MS, Sheriff H, Dalmau J, et al. The frequency of autoimmune n-methyl-d-aspartate receptor encephalitis surpasses that of individual viral Etiologies in young individuals enrolled in the California encephalitis project. Clin Infect Dis. [Internet]. 2012;54(7):899–904. Available from. https://academic.oup.com/cid/article-lookup/doi/10.1093/cid/cir1038
- Dalmau J, Armangué T, Planagumà J, et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol [Internet]. 2019;18(11):1045–1057. Available from. https://linkinghub.elsevier.com/retrieve/pii/S1474442219302443
- Serra-Mestres J, Villagrasa-Blasco B, Thacker V, et al. Catatonia in N-methyl-d-aspartate receptor antibody encephalitis: phenomenological characteristics from a systematic review of case reports. Gen Hosp Psychiatry. 2020;64:9–16.
- Dubey D, David WS, Reynolds KL, et al. Severe neurological toxicity of immune checkpoint inhibitors: growing spectrum. Ann Neurol [Internet]. 2020;87(5):659–669. Available from. https://onlinelibrary.wiley.com/doi/10.1002/ana.25708
- Nóbrega PR, Jwl TJ, Simabukuro MM, et al. Encefalites autoimunes.In: Frota NAF, Siqueira-Neto JI, Balthazar MLF, et al. editors. Neurol Cogn e do Envelhec do conhecimento básico à abordagem clínica. [Internet]. Omnifarma: São Paulo; 2016. 311–330. Available from. http://biblioteca.portalabn.org
- Mandel-Brehm C, Dubey D, Kryzer TJ, et al. Kelch-like protein 11 antibodies in seminoma-associated paraneoplastic encephalitis. N Engl J Med. [Internet]. 2019;381:47–54. Available from. ;(1):. : http://www.nejm.org/doi/10.1056/NEJMoa1816721
- Schuele SU. Evaluation of seizure etiology from routine testing to genetic evaluation. Contin Lifelong Learn Neurol. [Internet]. 2019;25(2):322–342. Available from. http://insights.ovid.com/crossref?an=00132979-201904000-00005
- Blinder T, Lewerenz J. Cerebrospinal fluid findings in patients with autoimmune encephalitis—a systematic analysis. Front Neurol. [Internet]. 2019;10. Available from. ;: https://www.frontiersin.org/article/10.3389/fneur.2019.00804/full
- Escudero D, Guasp M, Ariño H, et al. Antibody-associated CNS syndromes without signs of inflammation in the elderly. Neurology. 2017;89(14):1471–1475
- Swayne A, Tjoa L, Broadley S, et al. Antiglycine receptor antibody related disease: a case series and literature review. Eur J Neurol. 2018;25(10):1290–1298
- Tohid H. Anti-glutamic acid decarboxylase antibody positive neurological syndromes. Neurosciences. 2016;21(3):215–222.
- van Sonderen A, Thijs RD, Coenders EC, et al. Anti-LGI1 encephalitis. Neurology. [Internet]. 2016;87(14):1449–1456. Available from. http://www.neurology.org/lookup/doi/10.1212/WNL.0000000000003173
- Yang S, Qin J, Li J, et al. Rapidly progressive neurological deterioration in anti-AMPA receptor encephalitis with additional CRMP5 antibodies. Neurol Sci. 2016;37(11):1853–1855
- Graus F, Santamaría J. Understanding anti-IgLON5 disease. Neurol - Neuroimmunol Neuroinflammation. [Internet]. 2017;4(5):e393. Available from. http://nn.neurology.org/lookup/doi/10.1212/NXI.0000000000000393
- Jf H, Jessen F, Kuhn J. [Clinical phenomenology of Autoimmune Encephalitis]. Fortschr Neurol Psychiatr. 2016;84:271–280.
- Lancaster E. The diagnosis and treatment of autoimmune encephalitis. J Clin Neurol. 2016;12(1):1–13.
- Liang W, Zhang J, Saint-Martin M, et al. Structural mapping of hot spots within human CASPR2 discoidin domain for autoantibody recognition. J Autoimmun. [Internet]. 2019;96:168–177. Available from. https://linkinghub.elsevier.com/retrieve/pii/S0896841118302944
- Liu Q, Ma J, Huang Y, et al. High prevalence of electrocardiac abnormalities in anti-CASPR2 antibody-associated disease. J Neurol Neurosurg Psychiatry. [Internet]. 2019;90(1):117–118. Available from. https://jnnp.bmj.com/lookup/doi/10.1136/jnnp-2017-317527
- McKeon A. Autoimmune encephalopathies and dementias. Contin Lifelong Learn Neurol. 2016;22(2, Dementia):538–558.
- Piepgras J, Höltje M, Michel K, et al. Anti-DPPX encephalitis: pathogenic effects of antibodies on gut and brain neurons. Neurology. 2015;85(10):890–897
- Spatola M, Petit-Pedrol M, Simabukuro MM, et al. Investigations in GABA A receptor antibody-associated encephalitis. Neurology. 2017;88(11):1012–1020
- Geis C, Planagumà J, Carreño M, et al. Autoimmune seizures and epilepsy. J Clin Invest. [Internet]. 2019;129(3):926–940. Available from. https://www.jci.org/articles/view/125178
- Dutra LA, Abrantes F, Toso FF, et al. Autoimmune encephalitis: a review of diagnosis and treatment. Arq Neuropsiquiatr. 2018;76(1):41–49
- Jarius S, Paul F, Aktas O, et al. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation. [Internet]. 2018;15(1):134.Available from. http://link.springer.com/10.1007/s00115-018-0607-0
- Dubey D, Hinson SR, Jolliffe EA, et al. Autoimmune GFAP astrocytopathy: prospective evaluation of 90 patients in 1 year. J Neuroimmunol. 2018 Internet;321:157–163
- Spatola M, Sabater L, Planagumà J, et al. Encephalitis with mGluR5 antibodies: symptoms and antibody effects. Neurology. 2018;90(22):e1964–e1972
- Armangue T, Spatola M, Vlagea A, et al. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol. [Internet]. 2018;17:760–772. Available from. ;(9). https://linkinghub.elsevier.com/retrieve/pii/S1474442218302448. .
- Salovin A, Glanzman J, Roslin K, et al. Anti-NMDA receptor encephalitis and nonencephalitic HSV-1 infection. Neurol - Neuroimmunol Neuroinflammation. 2018;5(4):e458. [Internet]. Available from
- Makuch M, Wilson R, Al-Diwani A, et al. N-methyl-D-aspartate receptor antibody production from germinal center reactions: therapeutic implications. Ann Neurol. [Internet]. 2018;83(3):553–561. Available from. https://onlinelibrary.wiley.com/doi/10.1002/ana.25173
- Kreye J, Wenke NK, Chayka M, et al. Human cerebrospinal fluid monoclonal N methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis. Brain. [Internet]. 2016;139(10):2641–2652. Available from. https://academic.oup.com/brain/article-lookup/doi/10.1093/brain/aww208
- Sabatino JJJ, A-k P, Zamvil SS. B cells in autoimmune and neurodegenerative central nervous system diseases. Nat Rev Neurosci. [Internet]. 2019;20(12):728–745. Available from. (12). http://www.nature.com/articles/s41583-019-0233-2
- Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. [Internet]. 2016;15(4):391–404. Available from. https://linkinghub.elsevier.com/retrieve/pii/S1474442215004019
- Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. [Internet]. 2011;10(1):63–74. Available from. https://linkinghub.elsevier.com/retrieve/pii/S1474442210702532
- van Sonderen A, Ariño H, Petit-Pedrol M, et al. The clinical spectrum of Caspr2 antibody–associated disease. Neurology [Internet]. 2016;87(5):521–528. Available from. http://www.neurology.org/lookup/doi/10.1212/WNL.0000000000002917
- Review Article OM. Autoimmune encephalopathy for psychiatrists : when to suspect autoimmunity and what to do next. Psychosomatics. 2017;58(3):228–244. Internet
- Stavrou M, Yeo JM, Slater AD, et al. Case report: meningitis as a presenting feature of anti-NMDA receptor encephalitis. BMC Infect Dis. [Internet]. 2020;20(1):21.Available from. https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-020-4761-1
- Hao Q, Wang D, Guo L, et al. Clinical characterization of autoimmune encephalitis and psychosis. Compr Psychiatry. 2017 Internet;74:9–14
- Al-Diwani A, Handel A, Townsend L, et al. The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data. Lancet Psychiatry. [Internet]. 2019;6(3):235–246. Available from. https://linkinghub.elsevier.com/retrieve/pii/S221503661930001X• .
- Warren N, Siskind D, O’Gorman C. Refining the psychiatric syndrome of anti-N-methyl-d-aspartate receptor encephalitis.Acta Psychiatr Scand.2018;138(5):401–408; [Internet]. ;:. Available from https://doi.org/10.1111/acps.12941;
- Tan AH, Low SC, Tan CY, et al. Ictal catatonia: rare but not to be missed! Parkinsonism relat disord internet]. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1353802016303777 Parkinsonism & related disorders. 2016;32:137–139
- Lalanne L, Meriot ME, Ruppert E, et al. Attempted infanticide and suicide inaugurating catatonia associated with Hashimoto’s encephalopathy: a case report. BMC Psychiatry. 2016;16:16–19. Internet.
- Zandi MS, Deakin JB, Morris K, et al. Immunotherapy for patients with acute psychosis and serum N-Methyl d-Aspartate receptor (NMDAR) antibodies: a description of a treated case series. Schizophr Res [Internet]. 2014;160(1–3):193–195. Available from. https://linkinghub.elsevier.com/retrieve/pii/S0920996414006355
- Finke C, Kopp UA, Prüss H, et al. Cognitive deficits following anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry. [Internet]. 2012;83:195–198. Available from. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624763/pdf/nihms412728.pdf
- de Bruijn MAAM, Aarsen FK, van Oosterhout MP, et al. Long-term neuropsychological outcome following pediatric anti-NMDAR encephalitis. Neurology [Internet]. 2018;90:e1997–e2005. Available from. ;(22):. : http://www.neurology.org/lookup/doi/10.1212/WNL.0000000000005605
- Binks SNM, Veldsman M, Easton A, et al. Residual fatigue and cognitive deficits in patients after leucine-rich glioma-inactivated 1 antibody encephalitis. JAMA Neurol [Internet]. 2021;78:617.Available from. ;(5):. : https://onlinelibrary.wiley.com/doi/10.1002/ana.25665
- Kramina S, Kevere L, Bezborodovs N, et al. Acute psychosis due to non-paraneoplastic anti-NMDA-receptor encephalitis in a teenage girl: case report. PsyCh J. 2015;4(4):226–230
- Hermans T, Santens P, Matton C, et al. Anti-NMDA receptor encephalitis: still unknown and underdiagnosed by physicians and especially by psychiatrists? Acta Clin Belgica Int J Clin Lab Med. [Internet]. 2017;73:364–367.
- Rabinstein AA. Coma and brain death. Contin Lifelong Learn Neurol. [Internet]. 2018;24(6):1708–1731. Available from. http://insights.ovid.com/crossref?an=00132979-201812000-00009
- Wang M, Cao X, Liu Q, et al. Clinical features of limbic encephalitis with LGI1 antibody. Neuropsychiatr Dis Treat. [Internet]. 2017;13:1589–1596. Available from. https://www.dovepress.com/clinical-features-of-limbic-encephalitis-with-lgi1-antibody-peer-reviewed-article-NDT
- Brenton JN, Goodkin HP. Antibody-mediated autoimmune encephalitis in childhood. Pediatr Neurol. 2016;60:13–23. Internet
- Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. [Internet]. 2008;7(12):1091–1098. Available from. https://linkinghub.elsevier.com/retrieve/pii/S1474442208702242• .
- Beach RL, Barkan H, Deperalta E. The EEG in inflammatory CNS conditions. In: Schomer DL, da SFHL, editors. Niedermeyer’s electroencephalogr basic princ clin Appl relat fields. 6th ed. Lippincott Williams & Wilkins; 2011. p. 331–350.
- Tanaka K. Clinical profiles of Japanese patients with anti-NMDAR encephalitis and functional analysis of the anti-NMDAR antibodies. Rinsho Shinkeigaku. [Internet]. 2012;52(11):985–987.Available from.;(11). http://japanlinkcenter.org/DN/JST.JSTAGE/clinicalneurol/52.985?lang=en&from=CrossRef&type=abstract
- Schmitt SE, Pargeon K, Frechette ES, et al. Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology. [Internet]. 2012;79(11):1094–1100.Available from.;(11). http://www.neurology.org/cgi/doi/10.1212/WNL.0b013e3182698cd8
- Lawn ND, Westmoreland BF, Kiely MJ, et al. Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. Mayo Clin Proc. [Internet]. 2003;78(11):1363–1368.Available from.;(11). https://linkinghub.elsevier.com/retrieve/pii/S0025619611627158
- Gaspard N, Foreman BP, Alvarez V, et al. New-onset refractory status epilepticus: etiology, clinical features, and outcome. Neurology. [Internet]. 2015;85(18):1604–1613. Available from. http://www.ncbi.nlm.nih.gov/pubmed/26296517%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4642147
- Balu R, McCracken L, Lancaster E, et al. A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis. Neurology. [Internet]. 2019;92(3):e244–e252. Available from. http://www.neurology.org/lookup/doi/10.1212/WNL.0000000000006783
- Gorman MP, Gombolay GY, Mehan WA, et al. Case 27-2018: a 3-year-old boy with seizures. In: RC C, ES R, VM P, et al. editors. N Engl J Med. [Internet]. 2018;379:870–878. Available from. http://www.nejm.org/doi/10.1056/NEJMcpc1802824
- Lu J, Zhang J, Miao A, et al. Brain astrocytoma misdiagnosed as anti-NMDAR encephalitis: a case report. BMC Neurol. [Internet]. 2019;19(1):210.Available from:. https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-019-1436-x
- Çoban A, İsmail KC, Bilgiç B, et al. Evaluation of incidence and clinical features of antibody-associated autoimmune encephalitis mimicking dementia. Behav Neurol [Internet]. 2014;2014:1–4. Available from. http://www.hindawi.com/journals/bn/2014/935379/
- Bai HX, Zou Y, Lee AM, et al. diagnostic value and safety of brain biopsy in patients with cryptogenic neurological disease. Neurosurgery. [Internet]. 2015;77(2):283–295. Available from. https://academic.oup.com/neurosurgery/article-lookup/doi/10.1227/NEU.0000000000000756
- VanHaerents S, Gerard EE. Epilepsy emergencies: status epilepticus, acute repetitive seizures, and autoimmune encephalitis. Contin Lifelong Learn Neurol. [Internet]. 2019;25(2):454–476. Available from. http://insights.ovid.com/crossref?an=00132979-201904000-00011
- Dubey D, Kothapalli N, McKeon A, et al. Predictors of neural-specific autoantibodies and immunotherapy response in patients with cognitive dysfunction. J Neuroimmunol. [Internet]. 2018;323:62–72. Available from. https://linkinghub.elsevier.com/retrieve/pii/S0165572818302832The
- Walther S, Stegmayer K, Wilson JE, et al. Structure and neural mechanisms of catatonia. Lancet Psychiatry [Internet]. 2019;6(7):610–619. Available from. https://linkinghub.elsevier.com/retrieve/pii/S2215036618304747
- Brar K, Kaushik SS, Lippmann S. Catatonia Update. Prim Care Companion CNS Disord [Internet]. 2017;19(5). Available from: http://www.psychiatrist.com/PCC/article/Pages/2017/v19n05/16br02023.aspx
- Catatonia DJ. clinical Aspects and Correlates. J Neuropsychiatry Clin Neurosci. [Internet]. 2009; 21(4): 371–380. Available from.;21. http://neuro.psychiatryonline.org
- Fink M, Fricchione G, Rummans T, et al. Catatonia is a systemic medical syndrome. Acta Psychiatr Scand. 2016;133(3):250–251. [Internet]. Available from. doi:https://doi.org/10.1111/acps.12510
- Fink M, Taylor MA. Catatonia: a clinician’s guide to diagnosis and treatment. Cambridge University Press; 2003.
- Strawn JR, Keck PE, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry. [Internet]. 2007;164(6):870–876. Available from. https://linkinghub.elsevier.com/retrieve/pii/B9780128033760000101
- Nadler PL, Gonzales R. Commom symptoms. In: MA P, SJ M, Mw R, editors. Curr med diagnosis treat. 18th ed. McGraw-Hill Education LANGE; 2019. p. 20–45.
- Basu D, Gillman PK, Gnanadesigan N, et al. The serotonin syndrome. N Engl J Med. [Internet]. 2005;352:2454–2456. Available from. http://www.nejm.org/doi/abs/10.1056/NEJM200506093522320
- Taylor MA, Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry. 2003;160(7):1233–1241.
- Nitrini R, and Smid J. Demências por Príons. In: Frota NAF, Siqueira-Neto JI, and Balthazar MLF, editors. Neurol cogn e do envelhec do conhecimento básico à abordagem clínica. [Internet]. São Paulo: Omnifarma; 2016. 290–301. Available from. http://biblioteca.portalabn.org
- Fink M, Taylor MA, Syndrome TC. Arch Gen Psychiatry. Arch Gen Psychiatry. 2009;66(11):1173–1177.
- Rosebush PI, Mazurek MF. Catatonia and its treatment. Schizophr Bull. 2010;36(2):239–242.
- Gibson LL, Pollak TA, Blackman G, et al. The psychiatric phenotype of anti-NMDA receptor encephalitis. J Neuropsychiatry Clin Neurosci [Internet]. 2019;31(1):70–79. Available from. https://psychiatryonline.org/doi/10.1176/appi.neuropsych.17120343
- Mattozzi S, Sabater L, Escudero D, et al. Hashimoto encephalopathy in the 21st century. Neurology. [Internet]. 2020;94(2):e217–e224. Available from. http://www.neurology.org/lookup/doi/10.1212/WNL.0000000000008785
- Berlit P, Bösel J, Gahn G, et al. Neurological manifestations of COVID-19 - guideline of the German society of neurology. Neurol Res Pract Internet]. 2020;2:51.Available from:. ;(1):. : https://neurolrespract.biomedcentral.com/articles/10.1186/s42466-020-00097-7
- Correia AO, Feitosa PWG, de SMJL, et al. Neurological manifestations of COVID-19 and other coronaviruses: a systematic review. Neurol Psychiatry Brain Res. [Internet]. 2020;37:27–32. Available from. https://linkinghub.elsevier.com/retrieve/pii/S0941950020300713
- Siow I, Lee KS, Zhang JJY, et al. Encephalitis as a neurological complication of COVID‐19: a systematic review and meta‐analysis of incidence, outcomes, and predictors. Eur J Neurol. [Internet]. 2021;28(10):3491–3502. Available from. https://onlinelibrary.wiley.com/doi/10.1111/ene.14913
- Monti G, Giovannini G, Marudi A, et al. Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19. Seizure. [Internet]. 2020;81:18–20. Available from. https://linkinghub.elsevier.com/retrieve/pii/S1059131120302028
- Burr T, Barton C, Doll E, et al. N-Methyl-d-Aspartate receptor encephalitis associated with COVID-19 infection in a toddler. Pediatr Neurol. [Internet]. 2021;114:75–76. Available from. https://linkinghub.elsevier.com/retrieve/pii/S0887899420303295
- Panariello A, Bassetti R, Radice A, et al. Anti-NMDA receptor encephalitis in a psychiatric Covid-19 patient: a case report. Brain Behav Immun. [Internet]. 2020;87:179–181. Available from. https://linkinghub.elsevier.com/retrieve/pii/S0889159120308734
- Sarigecili E, Arslan I, Ucar HK, et al. Pediatric anti-NMDA receptor encephalitis associated with COVID-19. Child’s Nerv Syst [Internet]. 2021;1–4. Available from. https://link.springer.com/10.1007/s00381-021-05155-2
- Allahyari F, Hosseinzadeh R, Nejad JH, et al. A case report of simultaneous autoimmune and COVID-19 encephalitis. J Neurovirol. 2021;27(3):504–506. Internet
- Llorente Ayuso L, Torres Rubio P, Do Rosário RB, et al. Bickerstaff encephalitis after COVID-19. J Neurol. 2021;268(6):2035–2037. Internet
- Emekli AS, Parlak A, Göcen NY, et al. Anti-GAD associated post-infectious cerebellitis after COVID-19 infection. Neurol Sci. 2021;42(10):3995–4002
- Abbadessa G, Lavorgna L, Trojsi F, et al. Understanding and managing the impact of the Covid-19 pandemic and lockdown on patients with multiple sclerosis. Expert Rev Neurother. [Internet]. 2021;21(7):731–743. Available from. https://www.tandfonline.com/doi/full/10.1080/14737175.2021.1957673
- Nosadini M, Mohammad SS, Ramanathan S, et al. Immune therapy in autoimmune encephalitis: a systematic review. Expert Rev Neurother. 2015;15(12):1391–1419. Internet
- Mané-Damas M, Hoffmann C, Zong S, et al. Autoimmunity in psychotic disorders. Where we stand, challenges and opportunities. Autoimmun Rev. [Internet]. 2019;18(9):102348. Available from. https://linkinghub.elsevier.com/retrieve/pii/S156899721930148X
- Lee W-J, Lee S-T, Moon J, et al. Tocilizumab in autoimmune encephalitis refractory to rituximab: an institutional cohort study. Neurotherapeutics. 2016;13(4):824–832. Internet
- Dubey D, Britton J, McKeon A, et al. Randomized placebo‐controlled trial of intravenous immunoglobulin in autoimmune LGI1/CASPR2 epilepsy. Ann Neurol. [Internet]. 2020;87(2):313–323. Available from. https://onlinelibrary.wiley.com/doi/abs/10.1002/ana.25655
- Cooper CM, Cheung PW, Penney EB, et al. Case 15-2020: a 79-year-old man with hyponatremia and involuntary movements of the arm and face. In: RC C, ES R, VM P, et al. editors. N Engl J Med. [Internet]. 2020;382:1943–1950. Available from. http://www.nejm.org/doi/10.1056/NEJMcpc1913477
- de Bruijn MAAMAM, van Sonderen A, van Coevorden-hameete MH, et al. Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABA B R encephalitis. Neurology. [Internet]. 2019;92(19):e2185–e2196. Available from. http://www.neurology.org/lookup/doi/10.1212/WNL.0000000000007475
- Mittal MK, Rabinstein AA, Hocker SE, et al. Autoimmune encephalitis in the ICU: analysis of phenotypes, serologic findings, and outcomes. Neurocrit Care. [Internet]. 2016;24(2):240–250. Available from. http://link.springer.com/10.1007/s12028-015-0196-8
- Granata T, Matricardi S, Ragona F, et al. Pediatric NMDAR encephalitis: a single center observation study with a closer look at movement disorders. Eur J Paediatr Neurol. [Internet]. 2018;22:301–307. Available from:. https://doi.org/https://doi.org/10.1016/j.ejpn.2018.01.012.
- Colpo GD, Leboyer M, Dantzer R, et al. Immune-based strategies for mood disorders: facts and challenges. Expert Rev Neurother Internet]. 2018;18(2):139–152. Available from. https://www.tandfonline.com/doi/full/10.1080/14737175.2018.1407242
- Funcia FR. Subfinanciamento e orçamento federal do SUS: referências preliminares para a alocação adicional de recursos. Cien Saude Colet. [Internet]. 2019;24(12):4405–4415. Available from. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232019001204405&tlng=pt
- Alexopoulos H, Dalakas MC. The immunobiology of autoimmune encephalitides. J Autoimmun. 2019;104:102339. Internet. DOI:https://doi.org/10.1016/j.jaut.2019.102339.
- Tatencloux S, Chretien P, Rogemond V, et al. Intrathecal treatment of anti- N -Methyl- d -aspartate receptor encephalitis in children. Dev Med Child Neurol. [Internet]. 2015;57(1):95–99. Available from. https://onlinelibrary.wiley.com/doi/10.1111/dmcn.12545
- Wang D, Wu Y, Ji Z, et al. A refractory anti-NMDA receptor encephalitis successfully treated by bilateral salpingo-oophorectomy and intrathecal injection of methotrexate and dexamethasone: a case report. J Int Med Res. [Internet]. 2020;48:1–7. Available from. http://journals.sagepub.com/doi/10.1177/0300060520925666
- Yang X-Z, Zhu H-D, Ren H-T, et al. utility and safety of intrathecal methotrexate treatment in severe Anti-N-methyl-D-aspartate receptor encephalitis. Chin Med J (Engl). [Internet]. 2018;131(2):156–160. Available from. https://journals.lww.com/00029330-201801200-00006
- Gough JL, Coebergh J, Chandra B, et al. Electroconvulsive therapy and/or plasmapheresis in autoimmune encephalitis? World J Clin Cases Internet]. 2016;4(8):223.Available from. http://www.wjgnet.com/2307-8960/full/v4/i8/223.htm